Press release
Major Growth Driver Identified in 2025 Cancer biologics Market: Rising Prevalence Of Chronic Diseases Fuels Growth In The Cancer Biologics Market
Cancer Biologics Market
Cancer biologics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Over the past few years, the cancer biologics market has experienced rapid growth. The market, which was valued at $106.2 billion in 2024, is projected to increase to $117.03 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 10.2%. Factors leading to this growth in the historic period include a higher incidence of cancer, greater awareness of cancer biologics, enhanced efficacy and safety of cancer biologics, clearance of new cancer biologics, and a rise in acceptance of combination therapy.
Cancer biologics Market Size Forecast: What's the Projected Valuation by 2029?
In the coming years, the cancer biologics market is projected to experience robust growth. Its size is anticipated to reach $168.75 billion by 2029, with a compound annual growth rate (CAGR) of 9.6%. Factors contributing to growth during the forecast period include expanding indications, combination therapies, real-world evidence along with gene and cell therapies. The forecast period is also characterized by major trends such as advancements in biotechnology, personalized cancer biologics, biobetters, biosimilars, patient support services, and companion diagnostics.
View the full report here:
https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report
What Are the Drivers Transforming the Cancer biologics Market?
The escalation in the incidence of chronic ailments is a significant contributor to the growth of the cancer biologics market. Chronic diseases, which are long-term illnesses that adversely impact the health of individuals with disabilities, include the widespread ailment of cancer. The list of the most prevalent cancers features diseases such as breast cancer, lung and bronchus cancer, prostate cancer, colon and rectu*m cancer, melanoma of the skin, bladder cancer, non-Hodgkin lymphoma, kidney and renal pelvis cancer, endometrial cancer, leukemia, pancreatic cancer, thyroid cancer, and liver cancer. Notably, reports issued by the Centers for Disease Control and Prevention (CDC), a US-based public health agency, in February 2024 revealed a surge in the number of Americans managing multiple chronic illnesses, with 42% suffering from two or more, and 12% from as many as five or more. Therefore, the escalating incidence of chronic diseases is anticipated to propel further the growth of the cancer biologics market in the forthcoming years.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2563&type=smp
What Long-Term Trends Will Define the Future of the Cancer biologics Market?
Firms in the cancer biologics market are advancing predictive biomarkers, which guide doctors in choosing the suitable treatments for their patients, by making use of physical biomarkers to gauge the performance predictions. These biomarkers explore tumor expansion in individuals by examining the primary causative factors, considering variations in cancer etiology among patients. Furthermore, these biomarkers not only assist in early cancer diagnosis but also in determining the most economically viable treatment plan, particularly for biologics related to gene therapy.
Which Segments in the Cancer biologics Market Offer the Most Profit Potential?
The cancer biologics market covered in this report is segmented -
1) By Type: Monoclonal Antibodies, Vaccines, Cell And Gene Therapy, Other Types
2) By Application: Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma, Ovarian Cancer, Colorectal Cancer, Gastric Cancers, Other Applications
3) By Distribution Channel: Hospitals, Clinics, Other Distribution Channels
Subsegments:
1) By Monoclonal Antibodies: Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bispecific Monoclonal Antibodies
2) By Vaccines: Therapeutic Cancer Vaccines, Preventive Cancer Vaccines
3) By Cell And Gene Therapy: CAR T-Cell Therapy, Tumor-Infiltrating Lymphocytes (TIL) Therapy, Oncolytic Virus Therapy
4) By Other Types: Cytokines, Growth Factors, Fusion Proteins
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2563&type=smp
Which Firms Dominate the Cancer biologics Market by Market Share and Revenue in 2025?
Major companies operating in the cancer biologics market include AbbVie Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Eli Lilly and Company, AmgenInc., Bristol-Myers Squibb Company, Johnson & Johnson, Merck & Co.Inc., Novartis AG, Pfizer Inc., Celgene Corporation, Daiichi Sankyo Company Ltd., Seagen Inc., Takeda Pharmaceutical Company Limited, Biogen Inc., Vertex Pharmaceuticals Incorporated, Incyte Corporation, Karyopharm Therapeutics Inc., Kyowa Kirin Co Ltd., Ipsen Biopharmaceuticals Inc., Bayer AG, Biocon Limited, Genentech Inc., Gilead Sciences Inc., Puma Biotechnology, Regeneron Pharmaceuticals Inc.
Which Regions Offer the Highest Growth Potential in the Cancer biologics Market?
The countries covered in the cancer biologics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2563
"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Major Growth Driver Identified in 2025 Cancer biologics Market: Rising Prevalence Of Chronic Diseases Fuels Growth In The Cancer Biologics Market here
News-ID: 4151097 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
